BEFORE heading off to Greece to persuade its politicians to commit to the cannabis industry, former Canopy Growth Chief Executive Bruce Linton elaborated on his mission.
“If Greece legalised cannabis it would more than double its FDI (foreign direct investment). During my time with Canopy we attracted more investment than the whole of Greece,” he told an eager London audience.
Bruce Linton says he will continue his frequent TV appearances in order ‘to sell things’.
“It would be insane for the Greek Government not to do this; it would stop having to pay all those EU (European Union) loans, it would help solve its massive unemployment and it would boost tourism – which already accounts for 40% of its economy.”
During his time with Canopy Growth, the company he co-founded, Mr Linton attracted some $5bn of investment, which ‘is something the Greeks would love to have’, he said.
He continued: “Let’s have a party, and let’s see the Greek politicians make having a party an exclusive economic advantage. Who moves first, wins,” said Mr Linton at the Global Cannabis Institute conference in London, last November.
Mr Linton’s departure from Canopy wasn’t of his own volition and stemmed from the growing impatience of its investors; US drinks giant Constellation Brands.
Since leaving, he says that he had more than 200 offers and, after undertaking due diligence, he is actively investing and working with a number of new start-ups and emerging brands.
These include an appliance sharing website; ruckify, gift concierge; giftagram, cannabis brand; Slang Worldwide and medical cannabis firm; Viveo.
Despite the cannabis capital markets ‘drying-up’ with Canadian cannabis companies seeing their values plummet, he says it is still the ‘hottest topic on the globe’.
He says that the generalist, vertically-integrated model which was a hallmark of the initial Canadian firms – producer, manufacturer and retailer – will modify as the industry specialises.
Bruce Linton being interviewed on BNN Bloomberg.
While low-cost production will benefit emerging economies such as Colombia and China, he believes there will always be a place in the industry for ‘quality cultivators, supplying into the medical market’.
The Canadian Government has successfully managed to make ‘cannabis not fun’, as the existing law mandate almost total uniformity in products, he says.
If Greece legalised cannabis it would more than double its FDI (foreign direct investment). During my time with Canopy we attracted more investment than the whole of Greece.
Bruce Linton
However, he believes this will change and become ‘more interesting’ as edibles and other new products develop.
Mr Linton says there are still many barriers to overcome and recounts how even as a listed company he was not allowed to be pictured next to the opening and closing bells at the New York Stock Exchange.
He says he will continue his frequent TV appearances in order ‘to sell things’ and believes there is still so much to do in the cannabis space.
And reflecting on many future industry challenges, he mused ‘How can we ensure we deliver the correct CBD dosage requirement to pigs, so they don’t stress in a hot environment?’.
PRESS RELEASE FURTHER to the announcement dated 16 January 2023, Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on...
Bruce Linton: ‘I’ve Secured More Investment Capital Than Greece’
BEFORE heading off to Greece to persuade its politicians to commit to the cannabis industry, former Canopy Growth Chief Executive Bruce Linton elaborated on his mission.
“If Greece legalised cannabis it would more than double its FDI (foreign direct investment). During my time with Canopy we attracted more investment than the whole of Greece,” he told an eager London audience.
“It would be insane for the Greek Government not to do this; it would stop having to pay all those EU (European Union) loans, it would help solve its massive unemployment and it would boost tourism – which already accounts for 40% of its economy.”
During his time with Canopy Growth, the company he co-founded, Mr Linton attracted some $5bn of investment, which ‘is something the Greeks would love to have’, he said.
He continued: “Let’s have a party, and let’s see the Greek politicians make having a party an exclusive economic advantage. Who moves first, wins,” said Mr Linton at the Global Cannabis Institute conference in London, last November.
Mr Linton’s departure from Canopy wasn’t of his own volition and stemmed from the growing impatience of its investors; US drinks giant Constellation Brands.
Since leaving, he says that he had more than 200 offers and, after undertaking due diligence, he is actively investing and working with a number of new start-ups and emerging brands.
These include an appliance sharing website; ruckify, gift concierge; giftagram, cannabis brand; Slang Worldwide and medical cannabis firm; Viveo.
Despite the cannabis capital markets ‘drying-up’ with Canadian cannabis companies seeing their values plummet, he says it is still the ‘hottest topic on the globe’.
He says that the generalist, vertically-integrated model which was a hallmark of the initial Canadian firms – producer, manufacturer and retailer – will modify as the industry specialises.
While low-cost production will benefit emerging economies such as Colombia and China, he believes there will always be a place in the industry for ‘quality cultivators, supplying into the medical market’.
The Canadian Government has successfully managed to make ‘cannabis not fun’, as the existing law mandate almost total uniformity in products, he says.
However, he believes this will change and become ‘more interesting’ as edibles and other new products develop.
Mr Linton says there are still many barriers to overcome and recounts how even as a listed company he was not allowed to be pictured next to the opening and closing bells at the New York Stock Exchange.
He says he will continue his frequent TV appearances in order ‘to sell things’ and believes there is still so much to do in the cannabis space.
And reflecting on many future industry challenges, he mused ‘How can we ensure we deliver the correct CBD dosage requirement to pigs, so they don’t stress in a hot environment?’.
Second City Football Club Score A CBD First
Next Post2020 Cannabis Canada? – Covid-19, Cut-Backs And Consolidation
Peter
Related Posts
Related Posts
Business of Cannabis NYC Sessions: New York Will ‘Become The Most Sustainable, Equitable, and Demographically Diverse Market In The Industry’
Business of Cannabis’ third New York Sessions event took place last month (February 23), bringing together some of the leading...
Cantourage UK and CannFX make history by delivering the first ever Medical Cannabis Flower from New Zealand to the UK
CannFx’s dried flowers are the first New Zealand medical cannabis products to be made available in the United KingdomCannFx's indoor...
Bipartisan senators file bill to ease restrictions on industrial hemp farmers
UK Government’s Refusal To Publish Drug Decriminalisation Report ‘Further Evidence’ Of Them Ignoring ACMD and Evidence-Based Policy
Benefits of F1 Cannabis Hybrids from Royal Queen Seeds
Another Canadian cannabis producer pauses production over ‘edibles’ dispute with Health Canada
CONNECT
Related Posts
Related Posts
Cantourage UK and CannFX make history by delivering the first ever Medical Cannabis Flower from New Zealand to the UK
CannFx’s dried flowers are the first New Zealand medical cannabis products to be made available in the United KingdomCannFx's indoor...
UK Government’s Refusal To Publish Drug Decriminalisation Report ‘Further Evidence’ Of Them Ignoring ACMD and Evidence-Based Policy
A report from the government’s Advisory Council on the Misuse of Drugs (ACMD) that recommended the decriminalisation of drugs will...
Benefits of F1 Cannabis Hybrids from Royal Queen Seeds
F1 hybrids have revolutionised the way we grow and use plants. Now, F1 cannabis seeds are bringing growers, smokers, and...
MGC Pharmaceuticals Ltd (‘MGC Pharma’ or ‘the Company’) a European based pharmaceutical company specialising in the production and development of plant inspired medicines, has completed the pre-clinical study on CimetrA™, exploring the Mechanism of Action (MoA) of the product.
PRESS RELEASE FURTHER to the announcement dated 16 January 2023, Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on...
Proposed Changes To Germany’s Medical Cannabis Framework Would ‘Seriously Impact Both Patients And Industry’ If Brought In Tomorrow
TOMORROW, Germany’s Federal Joint Committee (G-BA) is expected to announce major changes to the country’s medical cannabis framework. These could...
Recent Posts
Related Posts
Business of Cannabis NYC Sessions: New York Will ‘Become The Most Sustainable, Equitable, and Demographically Diverse Market In The Industry’
Business of Cannabis’ third New York Sessions event took place last month (February 23), bringing together some of the leading...
Cantourage UK and CannFX make history by delivering the first ever Medical Cannabis Flower from New Zealand to the UK
CannFx’s dried flowers are the first New Zealand medical cannabis products to be made available in the United KingdomCannFx's indoor...
Bipartisan senators file bill to ease restrictions on industrial hemp farmers
INDUSTRIAL HEMP ACT Bipartisan senators file bill to ease restrictions on industrial hemp farmers A bipartisan pair of U.S. senators...
UK Government’s Refusal To Publish Drug Decriminalisation Report ‘Further Evidence’ Of Them Ignoring ACMD and Evidence-Based Policy
A report from the government’s Advisory Council on the Misuse of Drugs (ACMD) that recommended the decriminalisation of drugs will...
Benefits of F1 Cannabis Hybrids from Royal Queen Seeds
F1 hybrids have revolutionised the way we grow and use plants. Now, F1 cannabis seeds are bringing growers, smokers, and...
Subscribe to our mailing list to receives daily updates!
We won’t spam you
Categories
Browse by Tags